Feb 3, 2025 · Journavx (suzetrigine) is a new non-opioid pain-relieving tablet used to treat short-term (acute) moderate to severe pain. Journavx is a sodium channel blocker that relieves pain by blocking pain-sensing nerves around the body from transmitting pain …

Jan 30, 2025 · Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.

Ask your doctor about JOURNAVX, an oral medication that reduces pain signals before they reach the brain. a Acute pain is a type of pain that starts suddenly and lasts less than 3 months. It's often caused by an injury or surgery.

5 days ago · Journavx (suzetrigine) is a sodium channel blocker indicated for the treatment of moderate to severe acute pain in adults. What Are Side Effects of Journavx? Side effects of Journavx include: rash. Seek medical care or call 911 at once if …

See information for healthcare professionals on JOURNAVX, a nonopioid treatment for moderate-to-severe acute pain in adults. See Important Safety Information and Prescribing Information.

Jan 31, 2025 · Journavx has a list price of $15.50 per pill, which is significantly more expensive than comparable opioids. However, it’s unclear to what extent insurers could cover the medicine, and patient ...

Jan 30, 2025 · A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

Journavx is an effective, well-tolerated medicine without evidence of addictive potential indicated for use across all types of moderate-to-severe acute pain.

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Jan 31, 2025 · Journavx was found to help reduce pain by blocking pain signals in the peripheral nervous system before pain signals reach the brain. Reshma Kewalramani, CEO...